Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00197132 | Study In Patients With Insulin Resistance | PHASE3 | COMPLETED | 18 | — | — | Oct 1, 2002 | Aug 1, 2003 | Dec 5, 2016 | 1 | Netherlands |
| Name | Type | Description |
|---|---|---|
| Avandia | DRUG | - |
Inclusion Criteria: * BMI 27-36 kg/m2 inclusive and at least two additional features of the metabolic syndrome or a first degree relative with a history of type 2 diabetes mellitus. BMI = Weight/height², (where weight is in kg, height in m). * Male or female aged 30 to 65 years, inclusive, at scree...